Literature DB >> 6609738

Effects of bepridil on the electrophysiological properties of guinea-pig ventricular muscles.

T Anno, T Furuta, M Itho, I Kodama, J Toyama, K Yamada.   

Abstract

Effects of bepridil, a new antianginal and potential antiarrhythmic agent, on transmembrane action potentials of ventricular muscles were examined in isolated right ventricular papillary muscles of guinea-pig. Bepridil at concentrations above 5 X 10(-6)M caused a dose-dependent decrease in both the maximum upstroke velocity (Vmax) and the action potential duration from the upstroke to 30% repolarization ( APD30 ). On the other hand, the resting potential (RP), the amplitude of action potential (AMP), and the action potential duration from the upstroke to 90% repolarization ( APD90 ) were not affected even at the highest concentration applied (10(-5)M). The curves relating membrane potential and Vmax were shifted by bepridil at 5 X 10(-6)M along the voltage axis in the direction of more negative potentials. The recovery kinetics of Vmax assessed by premature stimuli were definitely slowed by bepridil at above 10(-6)M. This effect was more pronounced with higher [K+]o (10 mM) than normal [K+]o (5 mM). Bepridil at 5 X 10(-6)M caused a rate-dependent decrease of Vmax (use-dependent block) with rapid onset and offset, as did lidocaine. Slow responses, which had been induced by isoprenaline (5 X 10(-6)M) in K+-depolarized preparations, were suppressed significantly by additional application of bepridil at 10(-5)M. These findings suggest that bepridil has electrophysiological characteristics similar to those both of Class Ib and Class IV antiarrhythmic drugs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609738      PMCID: PMC1986901          DOI: 10.1111/j.1476-5381.1984.tb16123.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Effect of lidocaine and quinidine on steady-state characteristics and recovery kinetics of (dV/dt)max in guinea pig ventricular myocardium.

Authors:  C M Chen; L S Gettes; B G Katzung
Journal:  Circ Res       Date:  1975-07       Impact factor: 17.367

Review 2.  Ionic mechanisms in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias.

Authors:  O Hauswirth; B N Singh
Journal:  Pharmacol Rev       Date:  1978-03       Impact factor: 25.468

Review 3.  Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels.

Authors:  L M Hondeghem; B G Katzung
Journal:  Biochim Biophys Acta       Date:  1977-11-14

4.  Slow recovery from inactivation of inward currents in mammalian myocardial fibres.

Authors:  L S Gettes; H Reuter
Journal:  J Physiol       Date:  1974-08       Impact factor: 5.182

Review 5.  Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil.

Authors:  M R Rosen; A L Wit; B F Hoffman
Journal:  Am Heart J       Date:  1975-05       Impact factor: 4.749

6.  [Comparison of the effects of bepridil, dipyridamole, and propranolol on the cardiac activity and the coronary venous debt in anesthetized dogs].

Authors:  M T Michelin; M Cheucle; P Duchene-Marullaz
Journal:  Therapie       Date:  1977 Jul-Aug       Impact factor: 2.070

7.  Activity of bepridil and other anti-anginals on cardiovascular modifications engendered by conditioned anxiety in the dog.

Authors:  P Piris; M Beaughard; D Cosnier; C Labrid
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-09

8.  Combined effects of rate membrane potential, and drugs on maximum rate of rise (Vmax) of action potential upstroke of guinea pig papillary muscle.

Authors:  C Chen; L S Gettes
Journal:  Circ Res       Date:  1976-06       Impact factor: 17.367

9.  Studies on the bradycardia induced by bepridil.

Authors:  M Beaughard; M Ferrier; C Labrid; J C Lamar; J Leboeuf; P Piris
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

10.  Cardiovascular pharmacology of bepridil (1[3 isobutoxy 2 (benzylphenyl) amino] propyl pyrrolidine hydrochloride) a new potential anti-anginal compound.

Authors:  D Cosnier; P Duchenne-Marullaz; G Rispat; G Streichenberger
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-01
View more
  8 in total

1.  Effects of bepridil on ventricular depolarization and repolarization of rabbit isolated hearts with particular reference to its possible proarrhythmic properties.

Authors:  T Osaka; I Kodama; J Toyama; K Yamada
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

2.  Effects of bepridil and lidocaine on the intraventricular conduction in acutely ischaemic and infarcted canine myocardium.

Authors:  H Hashimoto; N Satoh; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

3.  Effects of the calcium entry blocker bepridil on repolarizing and pacemaker currents in sheep cardiac Purkinje fibres.

Authors:  F Berger; U Borchard; D Hafner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

4.  Mechanism of inhibition of the sodium current by bepridil in guinea-pig isolated ventricular cells.

Authors:  T Nawada; Y Tanaka; I Hisatome; N Sasaki; A Ohtahara; H Kotake; H Mashiba; R Sato
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

5.  Antiarrhythmic and electrophysiological effects of SD-3212, a novel Na+ and Ca++ channel blocker, in anaesthetized dogs with myocardial infarction in comparison with its stereoisomer (SD-3211) and bepridil.

Authors:  S Nagashima; T Uematsu; S Araki; T Matsuzaki; M Fukuchi; H Hashimoto; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

6.  Effects of bepridil on transmembrane action potentials recorded from isolated canine cardiac tissues. Studies on normal and infarct-zone Purkinje fibres and ventricular muscle cells.

Authors:  K H Dangman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

7.  Effects of selective channel blocking agents on contractions and action potentials in K+-depolarized guinea-pig atria.

Authors:  J Brown; R J Marshall; E Winslow
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

8.  DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties.

Authors:  G Scholtysik; R Salzmann; R Berthold; J W Herzig; U Quast; R Markstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.